Home > News > Headline News


Please Note

Some news stories may require you to register or sign in.  MedPage, for example, has an easy and free subscription form that only needs to be completed once--well worth the effort to access their timely and important articles.

Click on title to read the full article.

Markers Could Predict Risk of Brain Metastasis in Breast Cancer Patients

November 22, 2015

By CancerNetwork

Serum matrix metalloproteinase 9 (MMP-9) and HER2 extra-cellular domain (HER2-ECD) might be predictive biomarkers for the metastasis of breast cancer to the brain

Blood Draw Could Detect AI Resistance in Breast Cancer

November 20, 2015

By CancerNetwork

Researchers in the United Kingdom have developed a sensitive blood-based assay that can detect mutations in the estrogen receptor gene ESR1, a known mechanism of resistance to aromatase inhibitors (AIs), in the circulating tumor DNA of patients with hormone receptor–positive breast cancer.

Medicine: Eyes on the target

November 19, 2015

By nature.com

Today, many patients with HER2-positive tumours are essentially having their cancer eradicated by receiving a double-hit of targeted therapy before surgery. Even patients diagnosed with late-stage, metastatic disease — once seen as an imminent death sentence — are living much longer than ever before.

Cancer Biomarker Researcher Brings Team to Houston Methodist

November 14, 2015

By news wise

Marchetti’s team also has identified biomarkers that could one day lead to a CTC biomarker test that may guide the treatment of brain metastatic breast cancer in patients.

Study of breast cancer metastasis upends conventional wisdom, suggesting new treatment strategy

November 13, 2015

By Medical Express

Breast cancer cells do not undergo a commonly accepted transformation in order to spread to distant organs such as the lungs, Weill Cornell Medicine investigators have found in a new study.

Living With Metastatic Breast Cancer: On Borrowed Time

November 13, 2015

By MedicalResearch.com Interview with: Shirley Mertz

MBCN President Shirley Mertz offers some insights on the realities of living with Stage IV breast cancer in this interview. "Scientists do not know why the disease returns as metastatic disease, and yet women are made to feel that a Stage IV diagnosis is their fault," says Shirley.

Cancer metastasis video wins AAMC top prize

November 12, 2015

By Woodruff Health Sciences Center

In a new video, Winship Cancer Institute researchers shows how they're isolating and studying the behavior of "leader" cells that may be the key to cancer metastasis.

First-in-class antibody-drug conjugate shows clinical benefit against metastatic triple-negative breast cancer

November 9, 2015

By Medical Express

IMMU-132, an anti-Trop-2 antibody-drug conjugate (ADC) was safe, tolerable, and yielded meaningful clinical activity in heavily pretreated patients with metastatic triple-negative breast cancer (TNBC)

The DeAngelo Williams Foundation and Susan G. Komen® Join Forces for New Campaign Extending Breast Cancer Fight beyond October

November 4, 2015

By Business Wire

“DeAngelo has proven time and again that he’s committed to reducing these death rates by raising funds for research, education, and access to quality cancer care for all women. We are so grateful to have such a dedicated and passionate player as a partner in our mission to end breast cancer forever.”

Study: Mammograms haven't cut rate of Advanced Breast Cancer

November 3, 2015

By The New England Journal of Medicine Marilynn Marchione The Associated Press

A new report raises fresh questions, suggesting that screening and early detection are not preventing the most dangerous forms of the disease. This should be posted soon on the New England Journal of Medicine website.
 1 2 3 >  Last ›